Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

Similar articles for PubMed (Select 23214060)

1.

[The latest progress in the pathogenesis and diagnosis of Graves' disease].

Kimura T, Okamoto Y.

Nihon Rinsho. 2012 Nov;70(11):1908-12. Review. Japanese.

PMID:
23214060
2.

Comparison of new different assay systems for thyrotropin receptor antibodies with reference to thyroid-stimulating antibodies and thyroid stimulation-blocking antibodies in Graves' disease.

Hirooka Y, Li C, Takagi J, Gotoh M, Habu S, Yasaka-Nomura T, Ishihara R, Nakasone Y, Nakamura R, Morikawa R, Otake K, Nogimori T, Ishizuki Y.

Int J Clin Pharmacol Res. 2004;24(4):111-6.

PMID:
15754915
4.
5.

Clinical review about TRAb assay's history.

Zöphel K, Roggenbuck D, Schott M.

Autoimmun Rev. 2010 Aug;9(10):695-700. doi: 10.1016/j.autrev.2010.05.021. Epub 2010 Jun 4. Review.

PMID:
20594972
6.

Interaction of thyroid-stimulating antibody with Graves' thyroid-stimulating hormone-binding antibody.

Ochi Y, Kajita Y, Hamazu M, Nagata A.

Horm Res. 2003;59(5):222-8.

PMID:
12714785
7.
8.

Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease.

Kamijo K, Murayama H, Uzu T, Togashi K, Olivo PD, Kahaly GJ.

Thyroid. 2011 Dec;21(12):1295-9. doi: 10.1089/thy.2011.0056. Epub 2011 Nov 8.

PMID:
22066477
9.

The role of TSH receptor antibodies in the management of Graves' disease.

Matthews DC, Syed AA.

Eur J Intern Med. 2011 Jun;22(3):213-6. doi: 10.1016/j.ejim.2011.02.006. Epub 2011 Mar 22. Review.

PMID:
21570635
10.

The negative correlation between thyrotropin receptor-stimulating antibodies and bone mineral density in postmenopausal patients with Graves' disease.

Amashukeli M, Korinteli M, Zerekidze T, Jikurauli N, Shanava S, Tsagareli M, Giorgadze E.

J Investig Med. 2013 Jun;61(5):842-7. doi: 10.231/JIM.0b013e31828fcafb.

PMID:
23612147
12.

Prognostic value of thyrotropin receptor antibodies (TRAb) in Graves' disease: a 120 months prospective study.

Cappelli C, Gandossi E, Castellano M, Pizzocaro C, Agosti B, Delbarba A, Pirola I, De Martino E, Rosei EA.

Endocr J. 2007 Dec;54(5):713-20. Epub 2007 Aug 3.

14.

Graves' ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: prevalence, natural history, and thyrotropin receptor antibody levels.

Khoo DH, Eng PH, Ho SC, Tai ES, Morgenthaler NG, Seah LL, Fong KS, Chee SP, Choo CT, Aw SE.

Thyroid. 2000 Dec;10(12):1093-100.

PMID:
11201855
15.

Assays for thyroid-stimulating antibodies and thyrotropin-binding inhibitory immunoglobulins in children with Graves' disease.

Shibayama K, Ohyama Y, Yokota Y, Ohtsu S, Takubo N, Matsuura N.

Endocr J. 2005 Oct;52(5):505-10.

17.
18.

Disseminated thyroid autonomy or Graves' disease: reevaluation by a second generation TSH receptor antibody assay.

Meller J, Jauho A, Hüfner M, Gratz S, Becker W.

Thyroid. 2000 Dec;10(12):1073-9.

PMID:
11201852
20.

Evaluation of TSH receptor antibody by 'natural in vivo human assay' in neonates born to mothers with Graves' disease.

Tamaki H, Amino N, Iwatani Y, Tachi J, Kimura M, Mitsuda N, Ichihara K, Tanizawa O, Miyai K.

Clin Endocrinol (Oxf). 1989 May;30(5):493-503.

PMID:
2575017
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk